Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7691832

Methods of treatment of inflammatory diseases

The Board of Regents of the University of Oklahoma · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691380

Combined methods for tumor coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678824

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678552

Method for selecting therapeutic agents for cancer treatment

Precision Therapeutics, Inc. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7670855

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamy

The Regents of the University of California · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666886

Compounds and methods for the diagnosis and treatment of amyloid associated diseases

The Regents of the University of California · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666581

Methods for preparing compositions comprising heat shock proteins useful for the treatment

University of Connecticut Health Center · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662999

Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors

The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655694

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655472

Treatment of disease by inducing cell apoptosis

The Regents of the University of California · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7648701

Peptide composition as immunogen for the treatment of allergy

United Biomedical, Inc. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7648695

Medicaments for chemotherapeutic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638507

Compositions for treatment of inflammatory diseases

The Board of Regents of the University of Oklahoma · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638501

Method of treatment of mitochondrial disorders

The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7625563

Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622461

Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of tr

ACADIA Pharmaceuticals Inc. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622118

Cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7619000

S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino)

The Board of Regents of the University of Texas System · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612107

Treatment and inhibition of disease conditions using flexible heteroarotinoids

The Board of Regents of the University of Oklahoma · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601516

Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment o

Syntonix Pharmaceuticals, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585852

Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferati

Solidago AG · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582289

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579188

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment o

The Regents of the University of California · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572448

Combined cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted